Literature DB >> 35098396

Alpha-lipoic acid preconditioning plus ischemic postconditioning provides additional protection against myocardial reperfusion injury of diabetic rats: modulation of autophagy and mitochondrial function.

Behnaz Mokhtari1,2, Mahdi Abdoli-Shadbad1,2, Alireza Alihemmati2, Aniseh Javadi3,4, Reza Badalzadeh5,6,7.   

Abstract

BACKGROUND: Investigating the interaction of diabetes with ischemic postconditioning (IPostC)-associated cardioprotection in myocardial ischemia/reperfusion (I/R) damage is of great clinical importance. The present work was designed to determine the possible synergistic effects of alpha-lipoic acid (LA) preconditioning and IPostC on myocardial I/R damage in type-II diabetic rats through modulating autophagy, and the involvement of mitochondrial function.
METHODS: High-fat diet/low dose of streptozotocin-induced type-II diabetic model with duration of 12 weeks was used in this study. LA (100 mg/kg/day) was administered orally in diabetic rats for 5 weeks before I/R. Myocardial I/R was established on Langendorff apparatus through the ligation of left anterior descending coronary artery for 35 min, then reperfusion for 60 min. IPostC was carried out immediately at the beginning of the reperfusion. At the end of the experiment, myocardial infarct size (IS), autophagy markers at both gene and protein levels, and mitochondrial ROS production and membrane potential were assessed.
RESULTS: Combined conditioning with LA and ischemia significantly decreased the IS of diabetic hearts (P < 0.05), however, single therapies had no significant effects. LA in combination with IPostC more significantly decreased LC3 and p62 mRNA levels (P < 0.01), and LC3II/LC3I and p62 protein levels (P < 0.01). Also, this combined therapy decreased mitochondrial ROS generation and membrane depolarization (P < 0.01).
CONCLUSIONS: Pretreatment with LA in diabetic rats notably restored cardioprotection by IPostC via modulating autophagy and restoring mitochondrial function. This combined conditioning might be an effective strategy to diminish I/R damage in diabetic hearts.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Alpha-lipoic acid; Autophagy; Diabetic heart; Ischemia/reperfusion injury; Ischemic postconditioning; Mitochondrial function

Mesh:

Substances:

Year:  2022        PMID: 35098396     DOI: 10.1007/s11033-021-06987-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  9 in total

1.  Chronic type-I diabetes could not impede the anti-inflammatory and anti-apoptotic effects of combined postconditioning with ischemia and cyclosporine A in myocardial reperfusion injury.

Authors:  Reza Badalzadeh; Ako Azimi; Alireza Alihemmati; Bahman Yousefi
Journal:  J Physiol Biochem       Date:  2016-10-22       Impact factor: 4.158

2.  Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy.

Authors:  Chun-jun Li; Qiu-mei Zhang; Ming-zhen Li; Jing-yun Zhang; Pei Yu; De-min Yu
Journal:  Chin Med J (Engl)       Date:  2009-11-05       Impact factor: 2.628

3.  Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin.

Authors:  Goltaj Bayrami; Pouran Karimi; Fariba Agha-Hosseini; Saeid Feyzizadeh; Reza Badalzadeh
Journal:  J Cardiovasc Pharmacol Ther       Date:  2017-09-13       Impact factor: 2.457

4.  Nesfatin-1 attenuates injury in a rat model of myocardial infarction by targeting autophagy, inflammation, and apoptosis.

Authors:  Maryam Naseroleslami; Masuomeh Sharifi; Kamran Rakhshan; Behnaz Mokhtari; Nahid Aboutaleb
Journal:  Arch Physiol Biochem       Date:  2020-08-07       Impact factor: 4.076

5.  Boosting autophagy in the diabetic heart: a translational perspective.

Authors:  Sebastiano Sciarretta; V Subbarao Boppana; Mahaa Umapathi; Giacomo Frati; Junichi Sadoshima
Journal:  Cardiovasc Diagn Ther       Date:  2015-10

6.  YiQiFuMai Powder Injection Protects against Ischemic Stroke via Inhibiting Neuronal Apoptosis and PKCδ/Drp1-Mediated Excessive Mitochondrial Fission.

Authors:  Yingqiong Xu; Yan Wang; Guangyun Wang; Xinyi Ye; Jiangwei Zhang; Guosheng Cao; Yazheng Zhao; Zhen Gao; Yuanyuan Zhang; Boyang Yu; Junping Kou
Journal:  Oxid Med Cell Longev       Date:  2017-12-24       Impact factor: 6.543

7.  Chronic treatment of (R)-α-lipoic acid reduces blood glucose and lipid levels in high-fat diet and low-dose streptozotocin-induced metabolic syndrome and type 2 diabetes in Sprague-Dawley rats.

Authors:  Hardik Ghelani; Valentina Razmovski-Naumovski; Srinivas Nammi
Journal:  Pharmacol Res Perspect       Date:  2017-04-03

8.  Human amniotic membrane mesenchymal stem cells-conditioned medium attenuates myocardial ischemia-reperfusion injury in rats by targeting oxidative stress.

Authors:  Behnaz Mokhtari; Yaser Azizi; Aliakbar Rostami Abookheili; Nahid Aboutaleb; Donya Nazarinia; Nasim Naderi
Journal:  Iran J Basic Med Sci       Date:  2020-11       Impact factor: 2.699

9.  LYAR Promotes Colorectal Cancer Progression by Upregulating FSCN1 Expression and Fatty Acid Metabolism.

Authors:  Yupeng Wu; Yu Zhou; Haiying Gao; Yajun Wang; Qingyu Cheng; Shikun Jian; Qi Ding; Wei Gu; Yanxue Yao; Jia Ma; Wenjuan Wu; Yuyun Li; Xuhui Tong; Xiaoyuan Song; Sai Ma
Journal:  Oxid Med Cell Longev       Date:  2021-12-06       Impact factor: 6.543

  9 in total
  3 in total

Review 1.  Protective and deleterious effects of autophagy in the setting of myocardial ischemia/reperfusion injury: an overview.

Authors:  Behnaz Mokhtari; Reza Badalzadeh
Journal:  Mol Biol Rep       Date:  2022-09-15       Impact factor: 2.742

2.  Alpha-lipoic acid potentiates the anti-arrhythmic effects of ischemic postconditioning in the setting of cardiac ischemia/reperfusion injury in diabetic rats.

Authors:  Sanaz Gholami; Behnaz Mokhtari; Reza Badalzadeh
Journal:  J Diabetes Metab Disord       Date:  2022-03-31

Review 3.  Preclinical multi-target strategies for myocardial ischemia-reperfusion injury.

Authors:  Yuqing Li; Yi Gao; Guangping Li
Journal:  Front Cardiovasc Med       Date:  2022-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.